id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2014-D-1814-0131,FDA,FDA-2014-D-1814,06 Reference 6 Fatal Sepsis Associated with Bacterial Contamination of Platelets - Utah and California August 2017,Supporting & Related Material,Background Material,2018-12-06T05:00:00Z,2018,12,,,2018-12-06T14:51:27Z,,0,0,090000648394dd60
FDA-2014-D-1814-0130,FDA,FDA-2014-D-1814,05 Reference 5 Bacterial culture reduces but does not eliminate the risk of septic transfusion reactions to single-donor platelets,Supporting & Related Material,Background Material,2018-12-06T05:00:00Z,2018,12,,,2018-12-06T14:50:31Z,,0,0,090000648394da84
FDA-2014-D-1814-0126,FDA,FDA-2014-D-1814,Bacterial Risk Control Strategies for Blood Collection Establishments and Transfusion Services to Enhance the Safety and Availability of Platelets for Transfusion Draft Guidance for Industry,Other,Guidance,2018-12-06T05:00:00Z,2018,12,2018-12-06T05:00:00Z,2019-02-05T04:59:59Z,2020-02-07T18:39:47Z,,0,0,090000648394da7f
FDA-2014-D-1814-0129,FDA,FDA-2014-D-1814,04 Reference 4 Transfusion-related sepsis a silent epidemic,Supporting & Related Material,Background Material,2018-12-06T05:00:00Z,2018,12,,,2018-12-06T14:49:40Z,,0,0,090000648394da83
FDA-2014-D-1814-0134,FDA,FDA-2014-D-1814,09 Reference 9 BPAC-Transcript-071818,Supporting & Related Material,Background Material,2018-12-06T05:00:00Z,2018,12,,,2018-12-06T14:53:56Z,,0,0,090000648394dd63
FDA-2014-D-1814-0128,FDA,FDA-2014-D-1814,03 Reference 3 Detection of septic transfusion reactions to platelet transfusions by active and passive surveillance,Supporting & Related Material,Background Material,2018-12-06T05:00:00Z,2018,12,,,2018-12-06T14:48:52Z,,0,0,090000648394da82
FDA-2014-D-1814-0125,FDA,FDA-2014-D-1814,"Bacterial Risk Control Strategies for Blood Collection Establishments and
Transfusion Services To Enhance the Safety and Availability of Platelets for Transfusion; Draft Guidance for Industry; Availability",Notice,Notice of Availability,2018-12-06T05:00:00Z,2018,12,2018-12-06T05:00:00Z,2019-02-05T04:59:59Z,2019-02-05T02:02:20Z,2018-26477,0,0,090000648394cd15
FDA-2014-D-1814-0132,FDA,FDA-2014-D-1814,07 Reference 7 Apheresis technology correlates with bacterial contamination of platelets and reported septic transfusion reactions,Supporting & Related Material,Background Material,2018-12-06T05:00:00Z,2018,12,,,2018-12-06T14:52:14Z,,0,0,090000648394dd61
FDA-2014-D-1814-0127,FDA,FDA-2014-D-1814,01 Reference 1 Detection of bacterial contamination in prestorage culture-negative apheresis platelets on day of issue with the Pan Genera Detection test,Supporting & Related Material,Background Material,2018-12-06T05:00:00Z,2018,12,,,2018-12-06T14:47:53Z,,0,0,090000648394da81
FDA-2014-D-1814-0133,FDA,FDA-2014-D-1814,08 Reference 8 Transcripts Day 2 BPAC-9-21-12,Supporting & Related Material,Background Material,2018-12-06T05:00:00Z,2018,12,,,2018-12-06T14:53:13Z,,0,0,090000648394dd62